征稿已开启

查看我的稿件

注册已开启

查看我的门票

已截止
活动简介

Advances in Inflammatory Bowel Diseases (AIBD 2017) is a conference that covers topics such as:

Pediatric Clinical

  • Investigator-initiated Uncontrolled Clinical Trials

  • Investigator-initiated Controlled Clinical Trials

  • Procedures and Diagnostics

  • Pharma-initiated Clinical Trials

  • Patient Care and Complications of Therapy

  • Epidemiology and Outcomes Research

  • Pediatric Surgery

  • Clinical Case Reports

Clinical

  • Investigator-initiated Uncontrolled Clinical Trials

  • Investigator-initiated Controlled Clinical Trials

  • Procedures and Diagnostics

  • Pharma-initiated Clinical Trials

  • Patient Care and Complications of Therapy

  • Epidemiology and Outcomes Research

  • Surgery

  • Clinical Case Reports

Nursing

  • Clinical Basic Research

  • Clinical Education

  • Clinical Practice

Basic Research

  • Microbiology

  • Genetics

  • Adaptive Immune System

  • Innate Immune System

  • Epithelial Cells

  • Cytokines, Chemokines, and Cell Signaling

  • Animal Models

征稿信息

重要日期

2017-08-15
摘要截稿日期
2017-09-15
摘要录用日期

征稿范围

Abstracts will be accepted in the following categories: CLINICAL or PEDIATRIC or NURSING. Please indicate which category is appropriate by checking the appropriate box in the online submission system.

Clinical Abstract Categories
C1. Investigator-initiated Controlled Clinical Trials
C2. Investigator-initiated Uncontrolled Clinical Trials
C3. Pharma-initiated Clinical Trials
C4. Procedures and Diagnostics
C5. Epidemiology and Outcomes Research
C6. Patient Care and Complications of Therapy
C7. Clinical Case Reports
C8. Surgery

Pediatric Clinical Abstract Categories
P1. Investigator-initiated Controlled Clinical Trials
P2. Investigator-initiated Uncontrolled Clinical Trials
P3. Pharma-initiated Clinical Trials
P4. Procedures and Diagnostics
P5. Epidemiology and Outcomes Research
P6. Patient Care and Complications of Therapy
P7. Clinical Case Reports
P8. Surgery

Nursing Abstract Categories
N1. Clinical Education
N2. Clinical Basic Research
N3. Clinical Practice
N4. Other

作者指南

Accepted format:

  • Abstracts must be in English

  • 9 point Arial font

  • 500 word count limit

  • Use a concise title in title case only

  • List affiliations of author(s) as briefly as possible, with city, province and country

  • Use standard and well-accepted abbreviations

  • When listing references, use standard and well-accepted formats

  • Abstract content should be single-spaced and typed in lower case

  • Abstracts shall be of original research and contain a concise statement of study aim

  • Please include the following four (4) parts of your abstract:

Background, Methods, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable

Previous Presentation, Publication and Duplication of Abstracts:

  • Abstracts will not be considered for presentation if they have been or will be presented before the 2017 Advances in IBD Conference.

  • Abstracts will not be considered for presentation if they have been or will be published as an article (includes manuscripts accepted for publication) in either printed or electronic format upon the abstract submission deadline.
    Abstracts will not be considered for presentation if they have been duplicated in any way.

  • Abstracts may not be submitted to more than one category.

  • Abstracts that have been submitted to the Advances in IBD Conference in previous years, and have not been accepted for poster or oral presentation, are eligible for submission but must contain new, additional information to be considered.

  • Violations of these policies could result in a sanction from submitting abstracts to this conference for the submitting author.

Presentation Formats

  • Oral presentations

  • Poster presentations

Abstracts for oral or poster presentations will be chosen by the Scientific Review Committee.
Oral Abstract Presentation: Oral abstracts will be 10 minute presentations, which is the total allotted time. Therefore presenters must plan accordingly to schedule audience participation and questions. Employees of commercial interests are not preferred oral abstract presenters, but authors on the abstract who are not employees of commercial interests are eligible to present their data, if selected.

Poster Abstract Presentation: Poster presentations encourage interaction and exchange between authors and attendees. Detailed information regarding presentation times will be forthcoming.

留言
验证码 看不清楚,更换一张
全部留言
重要日期
  • 会议日期

    11月09日

    2017

    11月11日

    2017

  • 08月15日 2017

    摘要截稿日期

  • 09月15日 2017

    摘要录用通知日期

  • 11月11日 2017

    注册截止日期

移动端
在手机上打开
小程序
打开微信小程序
客服
扫码或点此咨询